Leukemia Research
Volume 23, Issue 8 , Pages 731-740 , August 1999

A novel biphenotypic B-cell precursor leukemia cell line (NALM-29) carrying t(9;22)(q34;q11) established from a patient with acute leukemia

  • Yoshinobu Matsuo

      Affiliations

    • Fujisaki Cell Center, Hayashibara Biochemical Labs Inc., 675-1 Fujisaki, Okayama 702-8006, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-86-2768621; fax: +81-86-2742150
    • ,
  • Hans G. Drexler

      Affiliations

    • DSMZ-German Collection of Microorganisms and Cell Cultures, Deptartment of Human and Animal Cell Cultures, Braunschweig, Germany
    • ,
  • Makoto Takeuchi

      Affiliations

    • National Sanatorium Minami Okayama Hospital, Hayashima-cho, Okayama, Japan
    • ,
  • Kunzo Orita

      Affiliations

    • Fujisaki Cell Center, Hayashibara Biochemical Labs Inc., 675-1 Fujisaki, Okayama 702-8006, Japan

Received 25 January 1999 ,Accepted 19 March 1999.

References 

  1. First MIC Cooperative Study Group. Morphologic, immunologic, and cytogenetic (MIC) working classification of acute lymphoblastic leukemias. Cancer Genet Cytogenet 1986;23:189–97.
  2. Second MIC Cooperative Study Group. Morphologic, immunologic, and cytogenetic (MIC) working classification of the acute myeloid leukemias. Cancer Genet Cytogenet 1986;30:1–15.
  3. Third MIC Cooperative Study Group. Recommendations for a morphologic, immunologic, and cytogenetic (MIC) working classification of the primary and therapy-related myelodysplastic disorders. Cancer Genet Cytogenet 1986;32:1–10.
  4. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick JR, et al. Proposed revised criteria for the classification of the acute leukemias: A report of the French–American–British Cooperative Group. Ann. Intern. Med. 1985;103:620–625
  5. Wright S, Chucrallah A, Chong YY, Kantarjian H, Keating M, Albitar M. Acute lymphoblastic leukemia with myeloperoxidase activity. Am. J. Hematol. 1996;51:147–151
  6. Zaki SR, Austin GE, Swan D, Srinivasan A, Ragab AH, Chan WC. Human myeloperoxidase gene expression in acute leukemia. Blood. 1989;74:2096–2102
  7. Yoneda N, Tatsumi E, Teshigawara K, Nagata S, Nagano T, Kishimoto Y, et al. Lineage determination of CD7+CD5− CD2− and CD7+CD5+CD2− lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3ε, and CD3δ. Am. J. Hematol. 1994;45:310–320
  8. Zhou M, Findley HW, Zaki SR, Little F, Coffield LM, Ragab AH. Expression of myeloperoxidase mRNA by leukemic cells from childhood acute lymphoblastic leukemia. Leukemia. 1993;7:1180–1183
  9. Hu Z-B, Ma W, Uphoff CC, Metge K, Gignac SM, Drexler HG. Myeloperoxidase: expression and modulation in a large panel of human leukemia-lymphoma cell lines. Blood. 1993;82:1599–1607
  10. European Group for the Immunological Characterization of Leukemias, Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, Van’t Veer MB.: proposals for the immunological classification of acute leukemias. Leukemia 1995;9:1783–6.
  11. Matsuo Y. Drexler HG. Establishment and characterization of human B cell precursor-leukemia cell lines. Leu. Res. 1998;22:567–579
  12. Rosenfeld C, Gounter A, Choquet C, Venuat AM, Kayibanda B, Pico JL. Phenotypic characterization of a unique non-T, non-B acute lymphoblastic leukemia cell line. Nature. 1977;267:841–843
  13. Minowada J, Tsubota T, Greaves MF, Walters TR. A non-T, non-B human leukemia cell line (NALM-1): establishment of the cell line and presence of leukemia-associated antigens. J. Natl. Cancer Inst. 1977;59:83–87
  14. Minowada J, Koshiba H, Janossy G, Greaves MF, Bollum FJ. A Philadelphia chromosome positive human leukemia cell line (NALM-1) with pre-B characteristics. Leuk. Res. 1979;3:261–266
  15. Propp S, Lizzi FA. Philadelphia chromosome in acute lymphocytic leukemia. Blood. 1970;36:353–360
  16. Okabe M, Matsushima S, Morioka M, Kobayashi M, Abe S, Sakurada K, et al. Establishment and characterization of a cell line, TOM-1, derived from a patient with Philadelphia chromosome-positive acute lymphocytic leukemia. Blood. 1987;69:990–998
  17. Drexler HG. Leukemia cell lines: in vitro models for the study of chronic myelocytic leukemia. Leuk. Res. 1994;18:919–927
  18. Homma T, Suzuki K, Kudo Y, Inagawa M, Mizuno S, Yamaguchi K, et al. Preparation and characterization of monoclonal antibodies against human myeloperoxidase. Arch. Biochem. Biophys. 1989;273:189–196
  19. Seabright M. A rapid banding technique for chromosomes. Lancet. 1971;2:971–972
  20. Hopert A, Uphoff CC, Wirth M, Hauser H, Drexler HG. Specificity and sensitivity of polymerase chain reaction (PCR) in comparison with other methods for the detection of mycoplasma contamination in cell lines. J. Immunol. Methods. 1993;164:91–100
  21. Hane B, Tummler M, Jager K, Schleithoff L, Jansen JWG, Drexler HG. Differences in DNA fingerprints of continuous leukemia-lymphoma cell lines from different sources. Leukemia. 1992;6:1129–1133
  22. Grande A, Manfredini R, Tagliafico E, Balestri R, Pizzanelli M, Papa S, et al. All-trans-retinoic acid induces simultaneously granulocytic differentiation and expression of inflammatory cytokines in HL-60 cells. Exp. Hematol. 1995;23:117–125
  23. Matsuo Y, MacLeod RAF, Kojima K, Kuwahara K, Sakata A, Drexler HG, et al. A novel ALL-L3 cell line, BALM-16, lacking expression of immunoglobulin chains derived from a patient with hypercalcemia. Leukemia. 1997;11:2168–2174
  24. Johnson KR, Nauseef WM, Care A, Wheelock MJ, Shane S, Hudson S, et al. Characterization of cDNA clones for human myeloperoxidase: predicted amino acid sequence for multiple mRNA species. Nucl. Acid Res. 1987;15:2013–2028
  25. Kawasaki ES, Clark SS, Coyne MY, Smith SD, Champlin R, Witte ON, et al. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc. Natl. Acad. Sci. USA. 1988;85:5698–5702
  26. Yamada M, Hudson S, Tournay O, Bittenbender S, Shane SS, Lange B, et al. Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes. Proc. Natl. Acad. Sci. USA. 1989;86:5123–5127
  27. Ohyashiki K, Fujieda H, Miyauchi J, Ohyashiki JH, Tauchi T, Saito M, et al. Establishment of a novel heterotransplantable acute lymphoblastic leukemia cell line with a t(17;19) chromosomal translocation the growth of which is inhibited by interleukin-3. Leukemia. 1991;5:322–331
  28. Matsuo Y, Adachi T, Tsubota T, Imanishi J, Minowada J. Establishment and characterization of a novel megakaryoblastic cell line, MOLM-1, from a patient with chronic myelogenous leukemia. Human Cell. 1991;4:261–264
  29. Ogawa S, Kurokawa M, Tanaka T, Mitani K, Inazawa J, Hangaishi A, et al. Structurally altered Evi-1 protein generated in the 3q21q26 syndrome. Oncogene. 1996;13:183–191
  30. Pegoraro L, Matera L, Ritz J, Levis A, Palumbo A, Biagini G. Establishment of a Ph1-positive human cell line (BV-173). JNCI. 1983;70:447–453
  31. Matsuo Y, Ariyasu T, Ohmoto E, Kimura I, Minowada J. Biphenotypic t(9;22)-positive leukemia cell lines from a patient with acute leukemia: NALM-20, established at the onset; and NALM-21, NALM-22 and NALM-23, established after relapse. Human Cell. 1991;4:335–338
  32. Ariyasu T, Matsuo Y, Harashima A, Nakamura S, Takaba S, Tsubota T, et al. Establishment and characterization of ‘biphenotypic’ acute leukemia cell lines with a variant Ph translocation t(9;22;10)(q34;q11;q22). Human Cell. 1998;11:43–50
  33. Ferrari S, Mariano MT, Tagliafico E, Sarti M, Ceccherelli G, Selleri L, et al. Myeloperoxidase gene expression in blast cells with a lymphoid phenotype in case of acute lymphoblastic leukemia. Blood. 1988;72:873–876
  34. Stass SA, Mirro J Jr. Lineage heterogeneity in acute leukaemia: acute mixed lineage leukaemia and lineage switch. Clin Haematol 1986;15:811–27.
  35. Matsuo Y, Sugimoto A, Kuwahara K, Watanabe Y, Sakata A, Sakaguchi N, et al. Monoclonal antibody NU-B1 reacts with novel antigen on human B cells in mantle and marginal zones distinct from known CD molecules. Tissue Antigens. 1998;52:422–429
  36. Ohyashiki K, Miyauchi J, Ohyashiki JH, Saito M, Yaguchi M, Inatomi Y, et al. Interleukin-7 enhances colony growth and induces CD20 antigen of a Ph+acute lymphoblastic leukemia cell line OM9;22. Leukemia. 1993;7:1034–1040

PII: S0145-2126(99)00086-7

Leukemia Research
Volume 23, Issue 8 , Pages 731-740 , August 1999

Article Tools

* Image Usage & Resolution